NCT01897142 - A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Healthy

Interventions

BIOLOGICAL

PF-05230907

0.1 micrograms per kilogram of PF-05230907, IV bolus, single dose

DRUG

Placebo for PF-05230907

0.1 micrograms per kilogram of placebo for PF-05230907, IV bolus, single dose

BIOLOGICAL

PF-05230907

0.3 micrograms per kilogram of PF-05230907, IV bolus, single dose

DRUG

Placebo for PF-05230907

0.3 micrograms per kilogram of placebo for PF-05230907, IV bolus, single dose

BIOLOGICAL

PF-05230907

1 micrograms per kilogram of PF-05230907, IV bolus, single dose

DRUG

Placebo for PF-05230907

1 micrograms per kilogram of placebo for PF-05230907, IV bolus, single dose

BIOLOGICAL

PF-05230907

2 micrograms per kilogram of PF-05230907, IV bolus, single dose

DRUG

Placebo for PF-05230907

2 micrograms per kilogram of placebo for PF-05230907, IV bolus, single dose

BIOLOGICAL

PF-05230907

3 micrograms per kilogram of PF-05230907, IV bolus, single dose

DRUG

Placebo for PF-05230907

3 micrograms per kilogram of placebo for PF-05230907, IV bolus, single dose

BIOLOGICAL

PF-05230907

5 micrograms per kilogram of PF-05230907, IV bolus, single dose

DRUG

Placebo for PF-05230907

5 micrograms per kilogram of placebo for PF-05230907, IV bolus, single dose

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels